sunitinib hydrochloride
PolandDrugs containing this active substance
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib hydrochloride 13.646 mg ATC: L01XE04
Manufacturer: Bluepharma Pharmaceutical Industry, S.A.
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive, unresectable pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib hydrochloride 27.293 mg ATC: L01XE04
Manufacturer: Bluepharma Pharmaceutical Industry, S.A.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib hydrochloride 40.939 mg ATC: L01XE04
Manufacturer: Bluepharma Pharmaceutical Industry, S.A.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib hydrochloride 54.585 mg ATC: L01XE04
Manufacturer: Bluepharma Pharmaceutical Industry, S.A.